Coloma Jason Vinsider trades
In SEC Form 4 filings, Coloma Jason V is listed as Chief Executive Officer of Maze Therapeutics, Inc. (MAZE). In the last 90 days, Coloma Jason V sold $2.43M of Maze Therapeutics, Inc. (MAZE) on the open market and bought none. 4 of the 8 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| MAZEMaze Therapeutics, Inc. | Chief Executive Officer | 10 | Oct 2 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-03
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| MAZEMaze Therapeutics, Inc. | Oct 1 | Oct 2 | S | 2,593 | $27.02 | Sale −$70,073 | 15,558 | Yes | Form 4 |
| MAZEMaze Therapeutics, Inc. | Oct 1 | Oct 2 | S | 31,908 | $27.02 | Sale −$862,186 | 191,447 | Yes | Form 4 |
| MAZEMaze Therapeutics, Inc. | Sep 3 | Sep 4 | S | 11,282 | $26.01 | Sale −$293,482 | 27,491 | No | Form 4 |
| MAZEMaze Therapeutics, Inc. | Sep 3 | Sep 4 | S | 129 | $25.77 | Sale −$3,325 | 27,362 | No | Form 4 |
| MAZEMaze Therapeutics, Inc. | Sep 2 | Sep 4 | S | 9,852 | $26.38 | Sale −$259,856 | 40,148 | No | Form 4 |
| MAZEMaze Therapeutics, Inc. | Sep 2 | Sep 4 | S | 1,375 | $27.12 | Sale −$37,292 | 38,773 | No | Form 4 |
| MAZEMaze Therapeutics, Inc. | Sep 1 | Sep 3 | S | 2,593 | $26.31 | Sale −$68,214 | 18,151 | Yes | Form 4 |
| MAZEMaze Therapeutics, Inc. | Sep 1 | Sep 3 | S | 31,908 | $26.29 | Sale −$838,785 | 223,355 | Yes | Form 4 |
| MAZEMaze Therapeutics, Inc. | Sep 1 | Sep 3 | M | 50,000 | $0.00 | $0 | 50,000 | Yes | Form 4 |
| MAZEMaze Therapeutics, Inc. | Sep 1 | Sep 3 | M · derivative | 50,000 | $0.00 | $0 | 50,000 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.